CDC Casually Admits Covid Nose Swabs Ended Up in a Lab for Genomic Sequencing Analysis

By Cristina LailaPublished February 16, 2022 ShareTweetShare to GabTelegramShare The CDC on Wednesday casually admitted some of the Covid nose swabs ended up in a lab for genomic sequencing analysis. But don’t worry because only the virus will be used for the genomic sequencing analysis, the CDC said. Many Americans were forced to take nose swabsContinue reading “CDC Casually Admits Covid Nose Swabs Ended Up in a Lab for Genomic Sequencing Analysis”

WHAT IS REALLY IN THE C19 VACCINES?

20 august, 2021 A new report has just been released by The Scientists Club collating research on the real contents of the C19 ‘vaccines’. This article features a few highlights – to read the full report please download the PDF at the end. NB – In anticipation of the many emails I will get askingContinue reading “WHAT IS REALLY IN THE C19 VACCINES?”

La Quinta Columna: Analysis of vaccination vial confirms presence of graphene nanoparticles

JUNE 24, 2021 In program No. 63, La Quinta Columna (biostatistician Ricardo Delgado and Dr. José Luis Sevillano) shared some of the many photographs of the analyses that the team of researchers with whom they work have obtained after subjecting the substance to different techniques to determine each of its components.  As promised, they have delivered; the resultsContinue reading “La Quinta Columna: Analysis of vaccination vial confirms presence of graphene nanoparticles”

COVID-19 early treatment: real-time analysis of 722 studies

Treatments for Covid19 so far include more than 20 items:Amantadine,Amoxicillin,Artemisia annua/sweet wormwood,Azithromycin,Aspirin,Bromhexine,Budesonide,Colchicine,Clarithromycin,Doxycycline,Fluvoxamine,Hydroxychloroquine,Iodine,Ivermectin,NAC,Niacin,Omega 3s,Povidone,Proxalutamide,Vitamin C,Vitamin D3,Vitamin K2,Quercetin,Quinine bark/ cinchona officinalis,Zinc, https://c19early.com/ All the graphs are easier to read on the original site (above). Treatment Improvement  (early) Studies  (early) China India USA Indonesia Pakistan Brazil Nigeria Bangladesh Russia Mexico Japan Ethiopia Philippines Egypt Vietnam DR Congo Germany Iran TurkeyContinue reading “COVID-19 early treatment: real-time analysis of 722 studies”